Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
Morgan H. James, Erin J. Campbell, Christopher V. Dayas
Current topics in behavioral neurosciences (2017), pp. 197-219
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Optimized ultrasound neuromodulation for non-invasive control of behavior and physiology
Keith R. Murphy, Jordan S. Farrell, Jonas Bendig, et al.
Neuron (2024) Vol. 112, Iss. 19, pp. 3252-3266.e5
Closed Access | Times Cited: 15
Stress and central autonomic network
Guillaume Lamotte, Kamal Shouman, Eduardo E. Benarroch
Autonomic Neuroscience (2021) Vol. 235, pp. 102870-102870
Closed Access | Times Cited: 79
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Anhedonia in depression symptomatology: Appetite dysregulation and defective brain reward processing
Roberto Coccurello
Behavioural Brain Research (2019) Vol. 372, pp. 112041-112041
Closed Access | Times Cited: 76
Pathophysiological Bases of Comorbidity in Migraine
Claudia Altamura, Ilenia Corbelli, Marina de Tommaso, et al.
Frontiers in Human Neuroscience (2021) Vol. 15
Open Access | Times Cited: 76
Modulation of noradrenergic signalling reverses stress-induced changes in the hippocampus: Involvement of orexinergic systems
Masoumeh Sarfi, Mahmoud Elahdadi Salmani, Taghi Lashkarbolouki, et al.
Brain Research (2025), pp. 149491-149491
Open Access | Times Cited: 1
Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression
Clarissa D. Staton, Jazmine D. W. Yaeger, Delan Khalid, et al.
Neuropharmacology (2018) Vol. 143, pp. 79-94
Open Access | Times Cited: 59
Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy
Cliff H. Summers, Jazmine D. W. Yaeger, Clarissa D. Staton, et al.
Brain Research (2018) Vol. 1731, pp. 146085-146085
Open Access | Times Cited: 59
Increased neural connectivity between the hypothalamus and cortical resting-state functional networks in chronic migraine
Gianluca Coppola, Antonio Di Renzo, Barbara Petolicchio, et al.
Journal of Neurology (2019) Vol. 267, Iss. 1, pp. 185-191
Open Access | Times Cited: 56
Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
Morgan H. James, Jennifer E. Fragale, R. Nisha Aurora, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 5, pp. 717-719
Open Access | Times Cited: 51
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Lateral hypothalamus orexinergic inputs to lateral habenula modulate maladaptation after social defeat stress
Dan Wang, Ao Li, Keyi Dong, et al.
Neurobiology of Stress (2021) Vol. 14, pp. 100298-100298
Open Access | Times Cited: 46
Behavioral phenotype, intestinal microbiome, and brain neuronal activity of male serotonin transporter knockout mice
Hirotaka Shoji, Kazutaka Ikeda, Tsuyoshi Miyakawa
Molecular Brain (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 17
The contribution of orexins to sex differences in the stress response
Laura A. Grafe, Seema Bhatnagar
Brain Research (2018) Vol. 1731, pp. 145893-145893
Open Access | Times Cited: 54
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Mood‐related central and peripheral clocks
Kyle D. Ketchesin, Darius D. Becker‐Krail, Colleen A. McClung
European Journal of Neuroscience (2018) Vol. 51, Iss. 1, pp. 326-345
Open Access | Times Cited: 50
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Fear circuit–based neurobehavioral signatures mirror resilience to chronic social stress in mouse
Sarah Ayash, Thomas Lingner, Anna Ramisch, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 17
Open Access | Times Cited: 13
A Preliminary Report on the Effects of Daridorexant in Patients with Comorbid Insomnia and Substance Use Disorders
Marco Di Nicola, Maria Pepe, Lorenzo Bonomo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 378-378
Open Access
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Do orexin/hypocretin neurons signal stress or reward?
Daria Peleg‐Raibstein, Denis Burdakov
Peptides (2021) Vol. 145, pp. 170629-170629
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top